The HiTS/IPCdd facility brings together a set of skills and technologies to accelerate the discovery of bioactive molecules either using experimental (in vitro or cellular) screening or molecular modelling for drug design approches. 
More precisely, the objectives of the facility is to support the identification, understanding, validation, and screening of key signaling pathways of tumor development (e.g., enzymes, protein/protein interaction surfaces).